Robert Kleszcz

18PUBLICATIONS
24CO-AUTHORS
Molecular targetsChemotherapyNatural products and bioactive compoundsCancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Sep 13, 2025
The Targeted Inhibition of Histone Lysine Demethylases as a Novel Promising Anti-Cancer Therapeutic Strategy-An Update on Recent Evidence.

Jarosław Paluszczak, Robert Kleszcz

|Oct 25, 2024
Honokiol Is More Potent than Magnolol in Reducing Head and Neck Cancer Cell Growth.

Robert Kleszcz, Dawid Dorna, Maciej Stawny

|Jun 27, 2024
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells.

Dawid Dorna, Robert Kleszcz, Jarosław Paluszczak

|Jan 22, 2024
Anti-Aging Properties of Chitosan-Based Hydrogels Rich in Bilberry Fruit Extract.

Elżbieta Studzińska-Sroka, Magdalena Paczkowska-Walendowska, Cansu Erdem

|Dec 22, 2023
PRI-724 and IWP-O1 Wnt Signaling Pathway Inhibitors Modulate the Expression of Glycolytic Enzymes in Tongue Cancer Cell Lines.

Robert Kleszcz, Jarosław Paluszczak, Marta Belka

|Sep 09, 2023
Advantages of the Combinatorial Molecular Targeted Therapy of Head and Neck Cancer-A Step before Anakoinosis-Based Personalized Treatment.

Robert Kleszcz

Pageof 3

Frequent Collaborators

10 joint publications

Jarosław Paluszczak

9 joint publications

Violetta Krajka-Kuźniak

5 joint publications

Wanda Baer-Dubowska

3 joint publications

Maria Narożna